ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1713

Bank1 Signaling Shapes the Gut Microbiota Composition by Controlling the Gut Mucosal B-cell Response in Lupus

Georgina Galicia-Rosas, María Botía Sánchez, Daniel Toro-Domínguez, Lorena Albadalejo and Marta Alarcon-Riquelme, Center for Genomics and Oncological Research (GENYO), Granada, Spain

Meeting: ACR Convergence 2022

Keywords: Animal Model, B-Lymphocyte, microbiome, Mouse Models, Lupus, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: SLE – Animal Models Poster

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Mucosa-associated commensal bacteria have been shown to be involved in the pathogenesis of systemic lupus erythematosus (SLE). However, its exact role remains to be determined. The BANK1 gene is a susceptibility gene for SLE implicated in TLR7 signaling in B cells. In lupus prone B6.Sle1.yaa mice the absence of Bank1 resulted in diminished disease severity concomitant with reduced anti-dsDNA IgG antibody production. B cells play a critical role in the microbiota-immune system crosstalk. Thus, the purpose of this work was to determine the role of the Bank1 gene in the gut B-cell response and its influence on gut microbiota composition in steady-state and during disease.

Methods: Two TLR7-mediated models of lupus were used: the spontaneous TLR7Tg lupus prone-mice and the model induced with treatment with a TLR7 agonist Imiquimod, both in C57Bl/6 Bank1-sufficient and Bank1-deficient mice. Animals were either raised in separate cages by genotype (single cage) or both genotypes together (littermates). B cell populations resident in the gut associated lymphoid tissue (GALT) were characterized by flow cytometry, and immunoglobulin determination in serum and fecal matter were quantified by ELISA. Microbiome composition was determined by sequencing the V4 region of 16sRNA. Gut permeability was measured with FITC-Dextran.

Results: In the imiquimod model, Bank1 KO mice showed in steady-state, reduced frequency of CD19+B220+ and IgA+B220– B cell populations in the gut with lower levels of fecal free IgA. These differences between Bank1 KO and WT mice in B cell populations were not observed after lupus development. Conversely, IL-10-producing B cells in the gut readily increased in Peyer’s patches upon gut inflammation in Bank KO mice, but not in WT mice, correlating with lower splenomegaly. The absence of Bank1 also diminished disease severity in the TLR7tg lupus-prone mice with a concomitant reduction in serum pathogenic IgG antibodies and lower gut permeability. When analyzing microbiota composition, single cage Bank1 KO mice had the baseline and composition of their gut microbiome altered as compared with control mice. The appearance of specific species belonging to the genera Parabacteroides and Bacteroides upon the induction of lupus only in Bank1 KO mice was related with reduced disease severity. To determine the contribution of gut microbiota to lupus inflammation, the imiquimod-induced model in littermate mice that inherited the Bank1 KO microbiota was used. The results were similar to those observed in Bank1 KO mice grown separately from their WT counterparts. Levels of IL-10+ B cells were normalized across WT and Bank1 KO mice, suggesting a possible role of microbiota in regulatory B cell induction.

Conclusion: These results indicate a link between Bank1 and microbiome composition in the gut. Interestingly, specific species of microbiota were identified as associated with less severe lupus inflammation only in Bank1 deficient mice. The specific mechanisms behind changes in the migration of B cells to the GALT and microbiota composition remains to be determined, but this is the first link between Bank1 and environmental factors in the lupus context.


Disclosures: G. Galicia-Rosas, None; M. Botía Sánchez, None; D. Toro-Domínguez, None; L. Albadalejo, None; M. Alarcon-Riquelme, None.

To cite this abstract in AMA style:

Galicia-Rosas G, Botía Sánchez M, Toro-Domínguez D, Albadalejo L, Alarcon-Riquelme M. Bank1 Signaling Shapes the Gut Microbiota Composition by Controlling the Gut Mucosal B-cell Response in Lupus [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/bank1-signaling-shapes-the-gut-microbiota-composition-by-controlling-the-gut-mucosal-b-cell-response-in-lupus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bank1-signaling-shapes-the-gut-microbiota-composition-by-controlling-the-gut-mucosal-b-cell-response-in-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology